Antimicrobial Agents and Chemotherapy · 2006 · 91 citations · 16 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDiagnostic MicrobiologyMedical MicrobiologyAntibacterial PharmacologyAntibiotic ResistanceLinezolid Therapy
The in vitro activities of tigecycline and other antimicrobials against 51 isolates of Nocardia spp. were evaluated. MIC(90)s and MIC ranges were as follows: tigecycline, 4 and < or =0.06 to 8 mg/liter, respectively; minocycline, 2 and < or =0.06 to 2 mg/liter, respectively; linezolid, 1 and < or =0.06 to 2 mg/liter, respectively; moxifloxacin, 2 and < or =0.06 to >64 mg/liter, respectively; ertapenem, 32 and < or =0.06->64 mg/liter, respectively; imipenem, 2 and < or =0.06 to >64 mg/liter, respectively; meropenem, 8 and < or =0.06 to >64 mg/liter, respectively; amikacin, 1 and < or =0.06 to 32 mg/liter, respectively; and trimethoprim-sulfamethoxazole, 1/19 and < or =0.5/9.5 to >2/38 mg/liter, respectively.
16
Peter J. Petersen, N V Jacobus, Jason Weiss et al. · Antimicrobial Agents and Chemotherapy · 1999 · 411 citations · Full text
Antimicrobial susceptibility patterns of Nocardia asteroides
Richard J. Wallace, L C Steele, G Sumter et al. · Antimicrobial Agents and Chemotherapy · 1988 · 259 citations
Patricia S. Conville, Steven H. Fischer, Charles P. Cartwright et al. · Journal of Clinical Microbiology · 2000 · 128 citations · Full text